Showing 981-990 of 19239 results for "".
A Look at Immunizations Through Time
https://reachmd.com/programs/covid-19-frontlines/a-look-at-immunizations-through-time/11580/Immunization techniques have been evolving since the 1100s. Could the techniques of the past help us in our current hunt for a COVID-19 vaccine?Innovations in Less-Invasive Epilepsy Surgery
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/innovations-in-less-invasive-epilepsy-surgery/39963/Recent developments in epilepsy surgery underscore a growing trend toward reduced invasiveness and expanded clinical indications.Women In Aesthetics: Mary Gardner, DelNova, Inc
https://modernaesthetics.com/topics/skincare/women-in-aesthetics-mary-gardner-delnova-inc/35165/Dr. Google Is a Liar
https://reachmd.com/programs/book-club/dr-google-liar/10612/With many patients turning to the internet for the answer to their symptoms and ailments, how can we as healthcare providers win the information war?Integrating Perspectives: The Value of Patient and Caregiver Input
https://mededonthego.com/programs/cme/integrating-perspectives-the-value-of-patient-and-caregiver-input/35883/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Kappa-Opioid Settings: Real-World Evidence Insights
https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Patient-Centric ADT Intensification in Hormone-Sensitive Prostate Cancer: Balancing Efficacy, Safety, Quality of Life, and Survival
https://reachmd.com/programs/cme/patient-centric-adt-intensification-in-hormone-sensitive-prostate-cancer-balancing-efficacy-safety-quality-of-life-and-survival/27147/This education will help clinicians develop evidence-based and collaborative treatment plans for the management of hormone-sensitive prostate cancer (HSPC) with ADT intensification, leading to improved outcomes, reduced riOptimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
https://reachmd.com/programs/cme/optimizing-igan-care-achieving-lower-proteinuria-targets-with-combination-therapy/26631/Review data on combination therapy with sparsentan and SGLT2 inhibitors to achieve lower proteinuria in patients with IgA nephropathy.Inside the IgAN Clinic: Shared Decision-Making Into Practice
https://reachmd.com/programs/cme/inside-the-igan-clinic-shared-decision-making-into-practice/26633/Learn how to apply shared decision-making principles to align treatment goals and patient priorities when managing IgA nephropathy.Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.